melanotan 2 peptide results II Melanotan II Research Peptide –

Lower doses mean less medication drawn per injection, which means each vial lasts longer in terms of dose count, but the BUD does not change

FDA Approval Status: The Unapproved Drug Classification Is BPC-157 FDA-approved for human use

In animal studies, Epithalon has been shown to: Increase average and maximum lifespan Reduce chromosomal aberrations Delay the onset of age-related diseases Improve neuroendocrine function and melatonin secretion Regulate gene expression related to longevity Perhaps most notably, Epithalon has been found to reactivate telomerase , an enzyme that rebuilds telomeres and potentially resets the cellular aging clock

Topical Treatments